Grünwald, V.; Pink, D.; Egerer, G.; Schalk, E.; Augustin, M.; Deinzer, C.K.W.; Kob, V.; Reichert, D.; Kebenko, M.; Brandl, S.;
et al. Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial. Cancers 2022, 14, 5234.
https://doi.org/10.3390/cancers14215234
AMA Style
Grünwald V, Pink D, Egerer G, Schalk E, Augustin M, Deinzer CKW, Kob V, Reichert D, Kebenko M, Brandl S,
et al. Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial. Cancers. 2022; 14(21):5234.
https://doi.org/10.3390/cancers14215234
Chicago/Turabian Style
Grünwald, Viktor, Daniel Pink, Gerlinde Egerer, Enrico Schalk, Marinela Augustin, Christoph K. W. Deinzer, Viola Kob, Dietmar Reichert, Maxim Kebenko, Stephan Brandl,
and et al. 2022. "Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial" Cancers 14, no. 21: 5234.
https://doi.org/10.3390/cancers14215234
APA Style
Grünwald, V., Pink, D., Egerer, G., Schalk, E., Augustin, M., Deinzer, C. K. W., Kob, V., Reichert, D., Kebenko, M., Brandl, S., Hahn, D., Lindner, L. H., Hoiczyk, M., Ringsdorf, U., Hanker, L. C., Hempel, D., De Rivas, B., Wismann, T., & Ivanyi, P.
(2022). Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial. Cancers, 14(21), 5234.
https://doi.org/10.3390/cancers14215234